These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 26278819)

  • 1. Autophagy inhibition sensitizes KU-0063794-mediated anti-HepG2 hepatocellular carcinoma cell activity in vitro and in vivo.
    Yongxi T; Haijun H; Jiaping Z; Guoliang S; Hongying P
    Biochem Biophys Res Commun; 2015 Sep; 465(3):494-500. PubMed ID: 26278819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of MEK/ERK activation attenuates autophagy and potentiates pemetrexed-induced activity against HepG2 hepatocellular carcinoma cells.
    Tong Y; Huang H; Pan H
    Biochem Biophys Res Commun; 2015 Jan; 456(1):86-91. PubMed ID: 25446102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arenobufagin, a natural bufadienolide from toad venom, induces apoptosis and autophagy in human hepatocellular carcinoma cells through inhibition of PI3K/Akt/mTOR pathway.
    Zhang DM; Liu JS; Deng LJ; Chen MF; Yiu A; Cao HH; Tian HY; Fung KP; Kurihara H; Pan JX; Ye WC
    Carcinogenesis; 2013 Jun; 34(6):1331-42. PubMed ID: 23393227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dramatic suppression of colorectal cancer cell growth by the dual mTORC1 and mTORC2 inhibitor AZD-2014.
    Huo HZ; Zhou ZY; Wang B; Qin J; Liu WY; Gu Y
    Biochem Biophys Res Commun; 2014 Jan; 443(2):406-12. PubMed ID: 24309100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beclin 1-mediated autophagy in hepatocellular carcinoma cells: implication in anticancer efficiency of oroxylin A via inhibition of mTOR signaling.
    Zou M; Lu N; Hu C; Liu W; Sun Y; Wang X; You Q; Gu C; Xi T; Guo Q
    Cell Signal; 2012 Aug; 24(8):1722-32. PubMed ID: 22560876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C6 ceramide sensitizes the anti-hepatocellular carcinoma (HCC) activity by AZD-8055, a novel mTORC1/2 dual inhibitor.
    Liu M; Gu P; Guo W; Fan X
    Tumour Biol; 2016 Aug; 37(8):11039-48. PubMed ID: 26897748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The anti-hepatocellular carcinoma cell activity by a novel mTOR kinase inhibitor CZ415.
    Zhang W; Chen B; Zhang Y; Li K; Hao K; Jiang L; Wang Y; Mou X; Xu X; Wang Z
    Biochem Biophys Res Commun; 2017 Jun; 487(3):494-499. PubMed ID: 28366631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autophagy prevention sensitizes AKTi-1/2-induced anti-hepatocellular carcinoma cell activity in vitro and in vivo.
    Zhang Q; Yang M; Qu Z; Zhou J; Jiang Q
    Biochem Biophys Res Commun; 2016 Nov; 480(3):334-340. PubMed ID: 27756618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre-clinical evaluation of AZD-2014, a novel mTORC1/2 dual inhibitor, against renal cell carcinoma.
    Zheng B; Mao JH; Qian L; Zhu H; Gu DH; Pan XD; Yi F; Ji DM
    Cancer Lett; 2015 Feb; 357(2):468-75. PubMed ID: 25444920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. mTORC1 Up-Regulates GP73 to Promote Proliferation and Migration of Hepatocellular Carcinoma Cells and Growth of Xenograft Tumors in Mice.
    Chen X; Wang Y; Tao J; Shi Y; Gai X; Huang F; Ma Q; Zhou Z; Chen H; Zhang H; Liu Z; Sun Q; Peng H; Chen R; Jing Y; Yang H; Mao Y; Zhang H
    Gastroenterology; 2015 Sep; 149(3):741-52.e14. PubMed ID: 25980751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autophagy induction contributes to GDC-0349 resistance in head and neck squamous cell carcinoma (HNSCC) cells.
    Zhou Y; Peng Y; Tang H; He X; Wang Z; Hu D; Zhou X
    Biochem Biophys Res Commun; 2016 Aug; 477(2):174-80. PubMed ID: 27291151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CC-223 blocks mTORC1/C2 activation and inhibits human hepatocellular carcinoma cells in vitro and in vivo.
    Xie Z; Wang J; Liu M; Chen D; Qiu C; Sun K
    PLoS One; 2017; 12(3):e0173252. PubMed ID: 28334043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autophagy inhibition sensitizes WYE-354-induced anti-colon cancer activity in vitro and in vivo.
    Wang L; Zhu YR; Wang S; Zhao S
    Tumour Biol; 2016 Sep; 37(9):11743-11752. PubMed ID: 27020593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GDC-0980-induced apoptosis is enhanced by autophagy inhibition in human pancreatic cancer cells.
    Tang JY; Dai T; Zhang H; Xiong WJ; Xu MZ; Wang XJ; Tang QH; Chen B; Xu M
    Biochem Biophys Res Commun; 2014 Oct; 453(3):533-8. PubMed ID: 25285629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting mTOR by CZ415 Inhibits Head and Neck Squamous Cell Carcinoma Cells.
    Xie J; Li Q; Ding X; Gao Y
    Cell Physiol Biochem; 2018; 46(2):676-686. PubMed ID: 29621758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KU-0060648 inhibits hepatocellular carcinoma cells through DNA-PKcs-dependent and DNA-PKcs-independent mechanisms.
    Chen MB; Zhou ZT; Yang L; Wei MX; Tang M; Ruan TY; Xu JY; Zhou XZ; Chen G; Lu PH
    Oncotarget; 2016 Mar; 7(13):17047-59. PubMed ID: 26933997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of autophagy enhances adenosine‑induced apoptosis in human hepatoblastoma HepG2 cells.
    Zhou XT; Pu ZJ; Liu LX; Li GP; Feng JL; Zhu HC; Wu LF
    Oncol Rep; 2019 Feb; 41(2):829-838. PubMed ID: 30535464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SC-III3, a novel scopoletin derivative, induces autophagy of human hepatoma HepG2 cells through AMPK/mTOR signaling pathway by acting on mitochondria.
    Zhao P; Dou Y; Chen L; Li L; Wei Z; Yu J; Wu X; Dai Y; Xia Y
    Fitoterapia; 2015 Jul; 104():31-40. PubMed ID: 25964188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Azathioprine desensitizes liver cancer cells to insulin-like growth factor 1 and causes apoptosis when it is combined with bafilomycin A1.
    Hernández-Breijo B; Monserrat J; Román ID; González-Rodríguez Á; Fernández-Moreno MD; Lobo MV; Valverde ÁM; Gisbert JP; Guijarro LG
    Toxicol Appl Pharmacol; 2013 Nov; 272(3):568-78. PubMed ID: 23958494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dihydromyricetin induces autophagy in HepG2 cells involved in inhibition of mTOR and regulating its upstream pathways.
    Xia J; Guo S; Fang T; Feng D; Zhang X; Zhang Q; Liu J; Liu B; Li M; Zhu R
    Food Chem Toxicol; 2014 Apr; 66():7-13. PubMed ID: 24444546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.